These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19937998)

  • 1. Score tests for exploring complex models: application to HIV dynamics models.
    Drylewicz J; Commenges D; Thiébaut R
    Biom J; 2010 Feb; 52(1):10-21. PubMed ID: 19937998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical identifiability of HIV dynamics models.
    Guedj J; Thiébaut R; Commenges D
    Bull Math Biol; 2007 Nov; 69(8):2493-513. PubMed ID: 17557186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model selection and mixed-effects modeling of HIV infection dynamics.
    Bortz DM; Nelson PW
    Bull Math Biol; 2006 Nov; 68(8):2005-25. PubMed ID: 16900456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
    AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
    Ergünay K; Altinbaş A; Calik Başaran N; Unal S; Us D; Karabulut E; Ustaçelebi S
    Mikrobiyol Bul; 2008 Jul; 42(3):413-9. PubMed ID: 18822884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiple imputation method for missing covariates in non-linear mixed-effects models with application to HIV dynamics.
    Wu H; Wu L
    Stat Med; 2001 Jun; 20(12):1755-69. PubMed ID: 11406839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of artificial neural networks to predict virological response to combination HIV therapy.
    Larder B; Wang D; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; Monforte AD; Torti C; Zazzi M; Lane C
    Antivir Ther; 2007; 12(1):15-24. PubMed ID: 17503743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
    Anderson AM; Kosinski AS; Bartlett JA
    Antivir Ther; 2007; 12(7):1041-8. PubMed ID: 18018762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: relation to RNA copy number and CD4 T-cell count.
    Seyoum E; Wolday D; Girma M; Malmsten A; Meselle T; Gronowitz JS; Britton S
    J Med Virol; 2006 Feb; 78(2):161-8. PubMed ID: 16372295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modeling approach to the impact of HIV mutations on the immune system.
    Vergu E; Mallet A; Golmard JL
    Comput Biol Med; 2005 Jan; 35(1):1-24. PubMed ID: 15567349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of human immunodeficiency virus-infected individuals by delayed type hypersensitivity skin testing.
    Metersky ML; Yang P; Nielsen HS; Catanzaro A
    Ann Clin Lab Sci; 1998; 28(5):272-9. PubMed ID: 9784827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling HIV viral rebound using non-linear mixed effects models.
    Fitzgerald AP; DeGruttola VG; Vaida F
    Stat Med; 2002 Jul; 21(14):2093-108. PubMed ID: 12111889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of long-term HIV dynamics using semi-parametric non-linear mixed-effects models.
    Wu H; Zhang JT
    Stat Med; 2002 Dec; 21(23):3655-75. PubMed ID: 12436462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of long-term HIV dynamic studies using semiparametric mixed-effects models.
    Huang Y; Park JG; Zhu Y
    Biom J; 2008 Aug; 50(4):528-40. PubMed ID: 18615413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
    Achenbach CJ; Till M; Palella FJ; Knoll MD; Terp SM; Kalnins AU; Murphy RL
    HIV Med; 2005 Jan; 6(1):7-12. PubMed ID: 15670246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.